llumina Announces New $100 Million Share Repurchase Authorization
August 3, 2011
SAN DIEGO -- Illumina today announced that on August 1, 2011, its Board of Directors authorized the Company to repurchase, on a discretionary basis, up to $100 million of its outstanding common shares in the open market or in privately negotiated transactions, subject to market conditions and other factors. The previous discretionary $100 million share [...]
August 3, 2011
Hamburg: Olympus has introduced its OLYMPUS Stream software for optimising industrial analysis using a microscope. Built-in as part of the system, the instant Extended Focal Imaging (EFI) and manual Multiple Image Alignment (MIA) functions are powerful features that expand the range of imaging possibilities available, while significantly simplifying and speeding up the process. The instant [...]
August 3, 2011
SEATTLE--NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it is initiating the first in a series of studies to evaluate the clinical utility of the NanoString Breast Cancer Intrinsic Subtyping Assay. The initial investigation will utilize samples from the TransATAC study [...]
August 3, 2011
MADISON, Wis. - Thermo Fisher Scientific Inc., the world leader in serving science, today announced its updated Build-Your-Own FT-IR website. The site offers many options for configuring the high-performance Thermo Scientific Nicolet 6700 FT-IR spectrometer so any laboratory can design the ideal FT-IR to meet its unique analytical challenges. This flexibility, which includes several optical [...]
August 3, 2011
CENTER VALLEY, Pa. and HAMBURG, Germany – The VS120 virtual microscopy slide scanning system from Olympus scans faster than ever before, offers image deconvolution/deblurring for ultra-sharp images and provides important new fluorescence imaging capabilities. Virtual slide creation could not be simpler—just set the slide in place and press Start. The system creates outstanding bright field [...]
QIAGEN Welcomes Approval of Scheme by CELLESTIS Shareholders
August 3, 2011
VENLO, The Netherlands - QIAGEN N.V. ("QIAGEN") welcomes the announcement made today by Cellestis Limited ("Cellestis") that Cellestis shareholders have approved QIAGEN's acquisition of all of the ordinary shares in Cellestis shares by way of a scheme of arrangement ("Scheme"). Details of the voting are set out in Cellestis' announcement released earlier today. "We are [...]
Cynvenio Biosystems, Inc. Adds Amit Munshi and Simon Raab, Ph.D. to Its Board of Directors
August 3, 2011
WESTLAKE VILLAGE, Calif. -- Cynvenio Biosystems, Inc., a developer of high performance cell isolation technology for biomedical research and novel cancer diagnostics, today announced that Amit Munshi and Simon Raab, Ph.D. have joined its board of directors. Mr. Munshi, a leading Southern California biopharma executive, is president and CEO of Percivia, LLC ( www.percivia.com ), [...]
IntegenX and Promega Ink RapidHIT™ Human Identification System Reagent Supply Agreement
August 3, 2011
Madison, WI & Pleasanton, CA - IntegenX Inc. and Promega Corporation today announced that commercial deliveries of RapidHIT™ 200 Human Identification Systems will include Promega’s nucleic acid purification and short tandem repeat (STR) amplification reagents. Promega’s established STR chemistry will enable users of the automated, self-contained RapidHIT System to produce DNA profiles for human identification [...]
Gyros Completes Next Stage of Development Program with Expansion of Product Portfolio
August 3, 2011
Uppsala, Sweden: Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, announced today the completion of a development program initiated to fulfill the requirements of scientists using the Company’s immunoassay platform in the biopharmaceutical industry. The development program has seen the release of a number of software modules and services [...]
BD and Lab21 Collaborate to Develop Aspergillus Assay for New BD MAX™ Molecular Testing System
August 3, 2011
Baltimore, MD and Cambridge, UK – BD Diagnostics, a segment of global medical technology company BD, and Lab21, a global leader in personalized healthcare, announced today a collaboration to develop a state-of-the-art molecular diagnostic assay to detect the life-threatening Aspergillus fungus using the new fully automated BD MAX™ Molecular Testing System. “The potential to detect [...]
